Medicaid Drug Rebate Program (MDRP) Summit 2024
IntegriChain is proud to have been a sponsor of this year’s Medicaid Drug Rebate Program (MDRP) event, contributing thought leadership on key topics such as IRA rebates and IRA drug price negotiations and best practices around this topic. Our sessions delved into the latest IRA Medicare Part D changes, offering insights and best practices for navigating this evolving landscape and how pharmaceutical manufacturers can prepare for new rebates.
Jeff Baab
Partner, Advisory Services
Session: IRA Negotiation Insights, Potential Implications, and Best Practices for Preparation
Date | Time: Tuesday, September 24 | 10:55AM – 11:35 AM
Description: In this session Jeff Baab, Partner, Advisory Services and Kristin Hicks, Partner at Arnold and Porter, will cover topics including:
- Refresh on the Medicare Drug Price Negotiation Program
- Insights from the publication of MFPs from the first round of negotiation
- How may future rounds of negotiation differ?
- What to prepare and best practices on process
- Market access implications of the MFP and changing Part D dynamics
For more on the topics in this presentation, please read our consulting blog post on the IRA.
Jake Keenan
Vice President, GP Managed Services
Session: Taking Action on the IRA – Operationalizing the Upcoming New Rebates of the IRA and Discarded Drug Refunds
Date | Time: Tuesday, September 24 | 2:50 PM – 3:30 PM
Description: In this session, Keenan will explore how pharmaceutical manufacturers can start preparing for the various new rebates that are part of the Inflation Reduction Act along with the refunds due from the Discarded Drug units. This includes discussing the operational considerations in receiving, validating, and paying the new invoices. In addition Keenan will review what modifications to rebate systems and processes will be needed to be efficient and accurate in the new IRA environment.